Fasrose AS Capsule is a combination medication containing Rosuvastatin 10mg and Aspirin 75mg, designed to manage cardiovascular health by addressing multiple risk factors simultaneously. Rosuvastatin, a potent statin, works by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis, thereby effectively lowering low-density lipoprotein (LDL) cholesterol and triglycerides while modestly increasing high-density lipoprotein (HDL) cholesterol. This lipid-lowering effect helps reduce the risk of atherosclerosis and related cardiovascular events. Aspirin, a low-dose antiplatelet agent, inhibits cyclooxygenase enzymes, leading to decreased thromboxane A2 production, which reduces platelet aggregation and prevents blood clot formation. The combination of these two agents provides a synergistic effect in preventing heart attacks, strokes, and other complications in patients with a history of cardiovascular disease or those at high risk. Fasrose AS Capsule is typically prescribed for secondary prevention in patients with coronary artery disease, ischemic stroke, or peripheral arterial disease. It is important to use this medication under medical supervision, as it may cause side effects such as muscle pain, gastrointestinal discomfort, or increased bleeding risk. Regular monitoring of liver function, lipid levels, and blood parameters is recommended during therapy.